AMEREN CORP

For the period ended Mar 31, 2026. Filed May 8, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 8, 2026

AEE$114.02+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheet

CONSOLIDATED BALANCE SHEET

	March 31,2026	December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents	$—	$6
Accounts receivable – trade (less allowance for doubtful accounts of $15 and $17, respectively)	263	284
Accounts receivable – affiliates	63	15
Unbilled revenue	142	193
Miscellaneous accounts receivable	71	15
Inventories	509	492
Current regulatory assets	233	181
Other current assets	128	119
Total current assets	1,409	1,305
Property, Plant, and Equipment, Net	21,555	20,604
Investments and Other Assets:
Nuclear decommissioning trust fund	1,478	1,526
Regulatory assets (includes $437 and $443 related to VIEs, respectively)	1,462	1,450
Pension and other postretirement benefits	273	271
Other assets	273	244
Total investments and other assets	3,486	3,491
TOTAL ASSETS	$26,450	$25,400
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Current maturities of long-term debt (includes $23 and $23 related to VIEs, respectively)	$23	$23
Short-term debt	280	471
Accounts and wages payable	395	696
Accounts payable – affiliates	57	61
Taxes accrued	82	34
Interest accrued	90	99
Retainage payable	118	28
Other current liabilities	154	150
Total current liabilities	1,199	1,562
Long-term Debt, Net (includes $426 and $426 related to VIEs, respectively)	9,011	8,120
Long-term Debt, Net - Related Parties	87	87
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and tax credits, net	2,800	2,702
Regulatory liabilities	3,250	3,324
Asset retirement obligations	859	844
Other deferred credits and liabilities	241	184
Total deferred credits and other liabilities	7,150	7,054
Commitments and Contingencies (Notes 2, 8, 9, and 10)
Shareholders’ Equity:
Common stock, $5 par value, 150.0 shares authorized – 102.1 shares outstanding	511	511
Other paid-in capital, principally premium on common stock	3,579	3,229
Preferred stock	80	80
Retained earnings	4,833	4,757
Total shareholders’ equity	9,003	8,577
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$26,450	$25,400

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.